0001127602-17-026989.txt : 20170905 0001127602-17-026989.hdr.sgml : 20170905 20170905173137 ACCESSION NUMBER: 0001127602-17-026989 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170831 FILED AS OF DATE: 20170905 DATE AS OF CHANGE: 20170905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meyers James R CENTRAL INDEX KEY: 0001387521 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 171069680 MAIL ADDRESS: STREET 1: GILEAD SCIENCES, INC. STREET 2: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-08-31 0000882095 GILEAD SCIENCES INC GILD 0001387521 Meyers James R GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 EVP Worldwide Commercial Ops Common Stock 2017-08-31 4 M 0 60000 21.00 A 62715 D Common Stock 2017-08-31 4 S 0 43300 83.0142 D 19415 D Common Stock 2017-08-31 4 S 0 16700 83.6392 D 2715 D Non-qualified Stock Option (Right to Buy) 21.00 2017-08-31 4 M 0 60000 0 D 2017-10-22 Common Stock 60000 0 D The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. Sale prices reported for the transactions reported here range from $82.50 to $83.50. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $83.51 to $83.91. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ Marissa Song by Power of Attorney for James R. Meyers 2017-09-05